請輸入關鍵字:

熱門搜尋:

Respimat® re-usable inhaler wins 2020 Pharmapack Eco-Design Award

日期: 2020年2月6日 下午3:54

• Respimat® re-usable has a lower carbon footprint and reduces waste compared with single-use inhalers1,2,3
• The device has been designed with patient input and contains features that improve ease of handling and use4

INGELHEIM, Germany -- (BUSINESS WIRE) --

Boehringer Ingelheim announced today that its Respimat® re-usable inhaler device is the winner of the 2020 Pharmapack Eco-Design Award. The Pharmapack Awards celebrate the latest innovations from packaging companies within the drugs, medical devices, health products and veterinary drugs sectors.5

Respimat® re-usable is an enhanced version of the well-established Respimat® soft mist inhaler, providing benefits for the environment and patients.1,4 It significantly reduces waste and product carbon footprint (PCF)1,3,6 – while most disposable plastic inhaler devices need to be replaced after the medication provided is used up, Respimat® re-usable can be used with up to six medication cartridges before needing replacement.7,8,9 Respimat® is also propellant-free, meaning its CO2 emissions are 20 times lower than those of commonly used pressurized metered-dose inhalers.1,3 By 2025, it is expected that 776 tons of plastic waste and 14,300 tons of CO2 emissions will be prevented as a result of Respimat® re-usable. 776 tons of plastic waste equals more than 77.6 million 0.5-liter PET bottles.10 It was also designed to offer simplified handling, with an easy-to-read dose indicator, better grip for daily use and easy assembly, taking into account patient feedback.11

“We developed the Respimat® re-usable inhaler as part of our commitment to help patients and provide benefits beyond treatment,” said Dr. Paola Casarosa, Head of Global Therapeutic Areas at Boehringer Ingelheim. “Respimat® re-usable is the result of patient feedback, providing an inhaler with enhancements such as simplified handling and an easy-to-read dose indicator, and significantly reduced impact on the environment.11 A very important aim of Boehringer Ingelheim is to lower greenhouse gases and reduce waste, so we’re proud to be recognized for our efforts in this area.”

Boehringer Ingelheim views safeguarding the planet as an essential prerequisite wherever possible and maintains a focus on environmental protection.12 That is one of the major reasons Boehringer Ingelheim continues to invest in innovation and initiatives to protect the environment.12

Intended audiences:
This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about Boehringer Ingelheim’s receipt of the Pharmapack 2020 Eco-Design Award.

For references and notes to editors, please visit: http://www.boehringer-ingelheim.com/press-release/respimat-re-usable-wins-pharmapack-eco-design-award

View source version on businesswire.com: https://www.businesswire.com/news/home/20200205005611/en/

CONTACT:

Media Contact
Boehringer Ingelheim
Meike Bausinger
55216 Ingelheim/Germany
Phone: +49 6132 77 182085
Fax: +49 6132 77 6601
Email: press@boehringer-ingelheim.com

財華網所刊載內容之知識產權為財華網及相關權利人專屬所有或持有。未經許可,禁止進行轉載、摘編、複製及建立鏡像等任何使用。

如有意願轉載,請發郵件至 content@finet.com.hk,獲得書面確認及授權後,方可轉載。

下載APP 下載財華財經APP,把握投資先機
更多精彩内容,請點擊: 財華網(https://www.finet.hk/) 財華智庫網(https://www.finet.com.cn) 現代電視FINTV(http://www.fintv.hk)

視頻

快訊

17:31
【盈喜】時代天使(06699.HK)料年度淨利潤同比增加140%至200%
17:21
中國人民銀行決定授權中國銀行股份有限公司科倫坡分行擔任斯里蘭卡人民幣清算行
17:12
如祺出行(09680.HK)料年度股東應佔綜合虧損同比收窄不少於43.4%
17:01
軒竹生物-B(02575.HK)軒悅寧第三個適應症上市申請獲國家藥監局批准
16:48
巨濤海洋石油服務(03303.HK)料年度公司擁有人應佔溢利同比減少83.79%至67.58%
16:37
香港金管局與澳門金管局簽署修訂諒解備忘錄以進一步加強合作
16:28
香港2月樓宇買賣合約總值按年升119.7%
16:20
【異動股】港股跌幅榜前十,倢冠控股(08606.HK)跌32.71%,金威醫療(08143.HK)跌28.57%
16:20
【異動股】港股漲幅榜前十,中油燃氣(00603.HK)漲117.03%,百勤油服(02178.HK)漲71.23%
16:13
愛麗家居(603221.SH)美國工廠及墨西哥工廠產能利用率持續爬坡 均處於正常經營狀態